A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Description

The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.

Conditions

Children With Medical Complexity (CMC)

Talk to us

Study Overview

On this page

Study Details

Study overview

The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Condition
Children With Medical Complexity (CMC)
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English or Spanish-speaking
  • * Parent or legal guardian and primary caregiver of child who has medical complexity (defined by significant chronic conditions in ≥2 body systems, progressive conditions associated with decreased life expectancy, dependence on technology for \>6 months \[e.g., respiratory equipment, central lines, feeding tubes\], or progressive/metastatic malignancies) who was admitted to the acute or intensive care units
  • * The individual's child is ≤18 years old
  • * The individual's child was discharged home or is expected be discharged home on ≥1 daily medication.
  • * Willingness to be randomized to intervention group
  • * Willingness and ability to participate in study procedures
  • * Caregiver \<18 years old
  • * Poor visual acuity (\<20/50 corrected on Rosenbaum screener for in-person recruitment; by subject report for phone recruitment)
  • * Self-reported hearing difficulty
  • * Previously enrolled.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Alexander F Glick, MD, MS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2025-09-30